Investors

Corporate highlights and investors relations

OVERVIEW

Optimi HealthTM is developing a Canadian vertically integrated functional mushroom brand that focuses on the health and wellness food markets. The Company also intends to cultivate, extract, process and distribute high quality strains of fungi products at its Facilities located in Princeton, British Columbia.

In addition, the Company received a Research Exemption in January 2021 and applied for a Dealer’s License in November 2020 through its wholly owned subsidiary Optimi Labs relating to the use and scientific research on psilocybin mushrooms and the possession, distribution, sale, laboratory analysis of and research and development in respect of psilocybin. 

Read our Corporate Highlights here

turkey-tail-fungus-5241610_1920

TRADING CHARTS

CSE:OPTI

CHART COMING SOON

CSE: OPTI

OPTI Chart by TradingView
OPTI Chart by TradingView

CSE:OPTI

CHART COMING SOON

OTC: OPTHF

OPTHF Chart by TradingView
OPTHF Chart by TradingView

CSE:OPTI

CHART COMING SOON

FRA: 8BN

8BN Chart by TradingView
8BN Chart by TradingView

CORPORATE PROFILE

Optimi Health Corp.
330 – 1122 Mainland Street, Vancouver, BC V6B 5L1
Investor Relations:
Email: investors@optimihealth.ca
Phone: +1 (778) 930-1321
Trading Symbol: CSE: OPTI | OTC:OPTHF | FRA: 8BN
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
WKN: A2QQEL
Issued & Outstanding: (11/22/2021) 70,105,258
Incorporated – BC / May 27, 2020
Year End – September 30th

CONSULTANTS

Legal Counsel

Miller Thomson LLP

www.millerthomson.com

Auditor

Smythe CPA

www.smythecpa.com

Transfer Agent

Endeavor Trust
Corporation

www.endeavortrust.com

REGULATORY FILINGS

SEDAR (System for Electronic Document Analysis and Retrieval)

SEDAR PROFILE

SEDAR DOCUMENTS

HIGHLIGHTS

WELL-FUNDED REVENUE PATHWAY

  • Recent Initial Public Offering (IPO) oversubscribed raise of $20.7 million.
  • Financial investments encompass capital expenditures for facilities, licensing, e-commerce platform buildout, strategic acquisitions, G &A and working capital.
  • Agreement with Canadian Premier Supplements (“CPS”), to provide certain co-packaging and production services.
  • Laboratory and Services Agreement with Numinus Wellness Inc. to provide certain psychedelic R&D services and testing.
  • Supply agreement with North American Reishi Ltd. (“Nammex”) for the initial supply of organic mushroom extract of Chaga, Cordyceps, Lion’s Mane and Turkey Tail until Optimi farm facilities reach full harvest capacity.
  • Consulting services agreement with a University of Calgary business incubator for review, design, planning and/or conducting clinical trial studies for future Optimi products.

STRATEGIC BUSINESS ADVANTAGES

  • Vertically integrated operation: Cultivation to Consumer (CTC).
  • Potential multi-revenue generating assets: e-Commerce, farm and lab facilities.
  • International sales and growth opportunities through established B2B relationships.
  • Agreement with Numinus (Licensed Dealer) – resulting IP to be owned 100% by Optimi.
  • Consulting Agreement with University partner for multiple clinical trials with Optimi proprietary IP.

EXCEPTIONAL CULTIVATION FACILITIES

  • In-house Health Canada consulting.
  • Received Health Canada Research Exemption on January 13, 2021.
  • Submitted Health Canada Dealers License Application for large scale Psilocybin Cultivation.
  • Two 10,000 sq. ft. (each) GMP & EU GMP-capable facilities under construction.
  • Expansion opportunity: +25 acres permitted & zoned for use.

EXPERIENCED & PASSIONATE TEAM

  • Strong Advisory Team supporting all key aspects of the business.
  • Experienced management in cultivation, finance, nutraceutical distribution, wholesale, and retail.
  • Agreement to work with Canada’s biggest online Direct-To-Consumer (DTC) supplement retailer.
  • Experienced Team operates a recently completed, Health Canada approved, cannabis facility on adjacent property.

PREMIUM NUTRACEUTICALS CTC OPPORTUNITY

  • Submitted NPN applications for first 7 product offerings.
  • Supplement line has been manufactured & tested – launching Q1 2021.
  • Early entry into rapidly expanding marketplace, immediate revenue.
  • Turn-key influencer marketing programs planned with a strong pipeline of partners.

Download Our Presentation

CLICK HERE

Contact Investor Relations

Email: investors@optimihealth.ca

Phone: +1 (778) 930-1321

Latest News

Optimi Health Engages Expert Management Consultancy to Drive Corporate Visibility

3 November 2021 Corporate News
Read More

Optimi Health Appoints Principal Investigator for Clinical Dosing Study

19 October 2021 Corporate News
Read More

Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application

5 October 2021 Corporate News
Read More
Corporate News

Optimi Health Engages Expert Management Consultancy to Drive Corporate Visibility

3 November 2021
Read More
Corporate News

Optimi Health Appoints Principal Investigator for Clinical Dosing Study

19 October 2021
Read More
Corporate News

Optimi Health Natural Psilocybin Extraction Breakthrough Submitted for Provisional Patent Application

5 October 2021
Read More
All News

investors

STRATEGIC BUSINESS ADVANTAGES

  • Vertically integrated operation: Cultivation to Consumer (CTC)
  • Multi-revenue generating assets: E-Commerce, Facilities 1 & 2
  • International sales and growth opportunities through established relationship

BEST IN THE WORLD CULTIVATION FACILITIES​

  • In-house Health Canada consulting
  • Clear pathway to Health Canada Dealers License for Psilocybin Cultivation
  • Two GMP Certified 10,000 Sq ft. Facilities (N.A. & E.U.)
  • Expansion opportunity: 25 acres permitted & zoned for use

EXPERIENCED & PASSIONATE TEAM

  • Strong advisory team supporting all key aspects of the business
  • Experienced Management in finance, cultivation, distribution,wholesale, and retail
  • Operational experience in domestic and international commerce
  • Experienced construction team recently completedHealth Canada Licensed 35M Cannabis Facility on adjacent property

PREMIUM NUTRACEUTICALS CTC OPPORTUNITY

  • Strong market demand for Canadian grown, extracted and processed product
  • Early entry into rapidly expanding marketplace
  • Turn-key strategic influencer marketing programs arranged

HIGHLIGHTS

STRATEGIC BUSINESS ADVANTAGES

  • Vertically integrated operation: Cultivation to Consumer (CTC)
  • Multi-revenue generating assets: E-Commerce, Facilities 1 & 2
  • International sales and growth opportunities through established relationship

BEST IN THE WORLD CULTIVATION FACILITIES

  • In-house Health Canada consulting
  • Clear pathway to Health Canada Dealers License for Psilocybin Cultivation
  • Two GMP Certified 10,000 Sq ft. Facilities (N.A. & E.U.)
  • Expansion opportunity: 25 acres permitted & zoned for use

EXPERIENCED & PASSIONATE TEAM

  • Strong advisory team supporting all key aspects of the business
  • Experienced Management in finance, cultivation, distribution,wholesale, and retail
  • Operational experience in domestic and international commerce
  • Experienced construction team recently completedHealth Canada Licensed 35M Cannabis Facility on adjacent property

PREMIUM NUTRACEUTICALS CTC OPPORTUNITY

  • Strong market demand for Canadian grown, extracted and processed product
  • Early entry into rapidly expanding marketplace
  • Turn-key strategic influencer marketing programs arranged
OptimiTM

Sign up for free News Alerts

  • *